A Lithuanian company, Caszyme, is looking to develop new discoveries, innovative applications and top-quality research in the field of CRISPR-based molecular tools.
The Vilnius-based gene-editing company, which was formed in 2017, was founded by scientists with expertise in Cas9 and other CRISPR-Cas protein expression, purification and characterization, as well as bioinformatic analysis of CRISPR-Cas system.
Caszyme is exploring new Cas proteins for various applications, providing research services for CRISPR applications, and developing and characterizing new CRISPR-based molecular tools.
We interviewed Monika Paule, Caszyme’s CEO and co-founder at the Baltic Life Sciences event in Vilnius, Lithuania recently.
Jim Cornall is editor of Deeptech Digest and publisher at Ayr Coastal Media. He is an award-winning writer, editor, photographer, broadcaster, designer and author. Contact Jim here.
